Senzime

Senzime announced multiple hospital contracts for its next-generation TetraGraph system, with orders exceeding 110 monitors from US and Swiss hospitals. First customer deliveries have commenced.

Senzime AB secured an initial purchasing contract with a hospital of a top 5 US-based Integrated Delivery Network on the US East Coast for the installation and use of its TetraGraph neuromuscular monitoring system in all operating rooms.

Senzime AB has signed an agreement to acquire 100% of Respiratory Motion, Inc. for an initial consideration of USD 19 million plus potential earn-out of up to USD 25 million. The acquisition expands Senzime's patient monitoring portfolio.

Senzime has won a procurement in the US Midwest from a hospital chain of three hospitals for instruments and disposable sensors, with an initial order value exceeding SEK 1 million.